Peru Presidential Election 2026: Keiko Fujimori Takes Early Lead in First-Round Vote 
RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles 
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment 
U.S. Navy Deploys Warships to Clear Mines in Strait of Hormuz 
U.S.-Iran Nuclear Talks Resume in Islamabad Amid Strait of Hormuz Standoff 
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 
The four types of dementia most people don’t know exist 
Peter Magyar Ends Viktor Orbán's 16-Year Rule in Historic Hungary Election 
Trump Blasts Pope Leo as "Weak" Amid Foreign Policy and Immigration Disputes 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition 
Spain's Sanchez Visits China to Deepen Trade Ties Amid U.S. Tensions 
Viktor Orban Loses Power After 16 Years as Hungary's Tisza Party Claims Landslide Election Victory 
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology 
Hungary's Orban Loses Power as Magyar Wins in Landslide; U.S. Reactions Divided 
U.S. President Donald Trump asked the help of American pharmaceutical firms that are currently working on experimental COVID-19 treatments to offer their drugs to Boris Johnson. The British Prime Minister has been moved to the I.C.U. after his coronavirus symptoms worsened.
“I’ve asked two of the leading companies,” Donald Trump said during a press conference, The Guardian reported. “They’ve come with the solutions and just have done incredible jobs – and I’ve asked him to contact London immediately.”
Trump said that the drugs are already in London and ready for use. “They’ve really advanced therapeutics … and they have arrived in London already,” the U.S. President said. “The London office has whatever they need. We’ll see if we can be of help. We’ve contacted all of Boris’s doctors, and we’ll see what is going to take place, but they are ready to go.”
The President did not specifically mention the name of the drugs or the pharmaceutical companies that made them. However, The Guardian noted that Trump had an earlier conference with the heads of biotech and pharmaceutical firms Amgen, Genetech, Gilead and Regeneron, pointed out that
However, Trump revealed that it’s still not certain if Boris Johnson would opt for the experimental treatments. “They’ve had meetings with the doctors, and we’ll see whether or not they want to go that route,” he said. “But when you’re in intensive care it’s a big deal. So they’re there and they’re ready.”
Donald Trump expressed sadness over what happened to his British counterpart, whom he considers to be one of his closest allies. “We’re very saddened to hear that he was taken into intensive care this afternoon, a little while ago, and Americans are all praying for his recovery,” Trump said. “He’s been a really good friend. He’s been really something very special: strong, resolute, doesn’t quit, doesn’t give up.”
Johnson has been moved to intensive care on Monday afternoon after his symptoms worsened, according to BBC. “Over the course of [Monday] afternoon, the condition of the prime minister has worsened and, on the advice of his medical team, he has been moved to the intensive care unit at the hospital,” a statement from No. 10 Downing Street reads.
